Curanex Pharmaceuticals Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

9.36M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	26.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CURX News

19 days ago - Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission - GlobeNewsWire
7 weeks ago - Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline - GlobeNewsWire
2 months ago - Curanex highlights patient case study in treatment of cancer cachexia - TheFly
2 months ago - Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care - GlobeNewsWire
2 months ago - Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company - GlobeNewsWire
2 months ago - Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission - GlobeNewsWire
2 months ago - Curanex completes dose-range finding toxicology study of Phyto-N - TheFly
2 months ago - Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission - GlobeNewsWire

More News